Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
61,869.62 +2,501.82 (+4.21%) CMC Crypto 200
1,341.31 +64.33 (+5.04%)
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:05PM EDT. Market open.
| Previous close | 3.7700 |
| Open | 3.9200 |
| Bid | 3.9000 x 200 |
| Ask | 3.9100 x 200 |
| Day's range | 3.8900 - 4.0700 |
| 52-week range | 3.2100 - 37.9800 |
| Volume | |
| Avg. volume | 1,856,462 |
| Market cap | 407.485M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.8300 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.91 |
- Business Wire
Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
NASHVILLE, Tenn., May 02, 2024--Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Simply Wall St.Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...
© 2024 Yahoo. All rights reserved.